Soleno Therapeutics, Inc.

NASDAQ (USD): Soleno Therapeutics, Inc. (SLNO)

Last Price

45.21

Today's Change

+1.71 (3.93%)

Day's Change

44.13 - 45.79

Trading Volume

161,692

Overview

Market Cap

1 Billion

Shares Outstanding

36 Million

Avg Volume

419,198

Avg Price (50 Days)

42.41

Avg Price (200 Days)

30.88

PE Ratio

-19.16

EPS

-2.36

Earnings Announcement

06-Aug-2024

Previous Close

43.50

Open

44.52

Day's Range

44.133 - 45.7899

Year Range

3.69 - 53.82

Trading Volume

161,692

Price Change Highlight

1 Day Change

3.93%

5 Day Change

-5.10%

1 Month Change

17.37%

3 Month Change

-2.71%

6 Month Change

92.30%

Ytd Change

19.13%

1 Year Change

973.87%

3 Year Change

198.42%

5 Year Change

49.21%

10 Year Change

-84.46%

Max Change

-84.46%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing Phase III clinical development program. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment